Inhibitory effects of propofol on Th17 cell differentiation.

Inhibitory effects of propofol on Th17 cell differentiation.

Immunopharmacol Immunotoxicol. 2017 May 30;:1-8

Authors: Lin CC, Chen DY, Tang KT, Chao YH, Shen CH, Lui PW

Abstract
Propofol (2,6-diisopropylphenol) is probably the most widely used intravenous anesthetic agent in daily practice. It has been reported to show immunomodulatory activity. However, the effect of propofol on the differention of T cells remains unclear. In this study, we demonstrated for the first time that propofol inhibited both interleukin (IL)-6 plus transforming growth factor-β (TGF-β)-induced Th17 cell differentiation in vitro and in LPS-challenged mice. Propofol also suppressed the IL-6-induced phosphorylation of Janus kinase-2 (JAK2)/signal transducer and activator of transcription (STAT3) pathway, a cytokine-activated essential transcription factor in Th17 cell development, which occurred concomitantly with the enhancement of suppressor of cytokine signaling-3 (SOCS3) expression involved in the downregulation of STAT3 phosphorylation. These data extend our knowledge of the immunosuppressive effects of propofol and their underlying mechanism.

PMID: 28555509 [PubMed - as supplied by publisher]

http://ift.tt/2rnWxAQ